CCL5 and neoplasm: In addition, tumor implants dissected at 6-weeks post-implantation demonstrated reduced Ccl5 levels, increased apoptosis (cleaved caspase-3 expression), and reduced cell proliferation (PCNA expression) in the Ccl5 KD groups (Supplementary Figure 2).